• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Cancer . A snapshot of COVID-19 infection in patients with solid tumors

tetano

Editor, Senior Moderator
Int J Cancer


. 2020 Dec 3.
doi: 10.1002/ijc.33420. Online ahead of print.
A snapshot of COVID-19 infection in patients with solid tumors


Jes?s Fuentes-Antr?s[SUP] 1 [/SUP], Ar?nzazu Manzano[SUP] 1 2 [/SUP], Gloria Marquina[SUP] 1 [/SUP], Mateo Paz[SUP] 1 3 [/SUP], Carlos Aguado[SUP] 1 [/SUP], M?nica Granja[SUP] 1 [/SUP], Javier Ben?tez[SUP] 1 [/SUP], Justo Ortega[SUP] 1 [/SUP], Araceli Priego[SUP] 1 [/SUP], Carlos Gonz?lez[SUP] 1 [/SUP], Julia Tejerina-Peces[SUP] 1 [/SUP], Paloma Flores[SUP] 1 [/SUP], Alfonso L?pez de Sa[SUP] 1 [/SUP], Carmen Toledano[SUP] 1 [/SUP], Jennifer Olalla[SUP] 1 [/SUP], Alicia de Luna[SUP] 1 [/SUP], Jorge Bartolom?[SUP] 1 [/SUP], Pedro P?rez-Segura[SUP] 1 [/SUP]



Affiliations

Abstract

Coronavirus disease 2019 (COVID-19) pandemic is affecting a high percentage of the population at an unprecedented rate. Cancer patients comprise a subgroup especially vulnerable to this infection. Herein, we present a prospective analysis of epidemiological, clinical, radiological and laboratory data of consecutive adult cancer patients seen in the Cl?nico San Carlos University Hospital (Madrid, Spain), and admitted to hospital and tested for COVID-19 between February 21 and May 8, 2020 due to clinical suspicion of infection. Data from 73 patients with confirmed COVID-19 and active solid tumors or diagnosed within the previous 5 years were analyzed. The most frequent malignancy was lung cancer (19%) and 54 patients (74%) were on active cancer treatment. Most common findings on presentation included cough (55%), fever (52%), and dyspnea (45%), and 32 (44%) patients showed oxygen saturation levels below 95%. Radiologically, 54 (73%) patients presented an abnormal pattern, the most frequent being infiltrates (64%). 18 (24.7%) patients died in hospital and 55 (75.3%) were discharged with clinical resolution of the event. Multivariable logistic regression adjusted for age and tumor stage showed higher odds of in-hospital death associated with a history of cardiovascular disease, hospitalization in the previous 30 days, and several features on admission including dyspnea, higher qSOFA score, higher C-reactive protein levels, and an abnormal neutrophil count. We present prospective, real-world evidence that can help articulate cancer care protocols for patients infected with SARS-CoV-2, with special focus on features on admission that can stratify patients with a higher risk of death from COVID-19.
 
Back
Top Bottom